scispace - formally typeset
A

Alessandra Mussi Ribeiro

Researcher at Federal University of São Paulo

Publications -  65
Citations -  1293

Alessandra Mussi Ribeiro is an academic researcher from Federal University of São Paulo. The author has contributed to research in topics: Reserpine & Parkinsonism. The author has an hindex of 18, co-authored 57 publications receiving 944 citations. Previous affiliations of Alessandra Mussi Ribeiro include Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto & University of Rio Grande.

Papers
More filters
Journal ArticleDOI

Improvement in physiological and psychological parameters after 6 months of yoga practice

TL;DR: Regular yoga practice can improve aspects of cognition and quality of life for healthy individuals and an indirect influence of emotional state on cognitive improvement promoted by Yoga practice can be proposed.
Journal ArticleDOI

Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.

TL;DR: It is described that repeated treatment with low doses of reserpine progressively induces alterations in motor function and an increase in striatal oxidative stress, indicating a possible application of this model in the study of the neuroprogressive nature of the motor signs in PD.
Journal ArticleDOI

Differential Cortical c-Fos and Zif-268 Expression after Object and Spatial Memory Processing in a Standard or Episodic-Like Object Recognition Task

TL;DR: In this paper, the authors evaluated whether there are different patterns of expression of the immediate early genes c-Fos and Zif-268 in these cortical areas after rats are exposed to object recognition tasks with different cognitive demands.
Journal ArticleDOI

Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine

TL;DR: Previous results showing that the gradual appearance of motor impairment induced by repeated treatment with a low dose of reserpine is preceded by short-term memory impairment, as well as accompanied by neurochemical alterations compatible with the pathology of PD are extended.
Journal ArticleDOI

Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.

TL;DR: In this paper, the authors highlight classical and recent experimental findings that support the face, pharmacological and construct validity of reserpine PD model and reason against the current rationale for its underuse.